Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol in Septic Shock: Hemodynamics and Microcirculation
ChiCTR2100049558Phase 4Completed
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esmolol in septic shock (2 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoints: Hemodynamic indicators, Oxygen metabolism indicators and 3 more. Started Mar 2021; status: completed.
02
Drugs
esmolol
03
Conditions
septic shock
Beyond the preview
Go deeper on ChiCTR2100049558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049558.